BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of €12.8 billion as of January 9, 2026. Its market cap has increased by 153.54% in one year.

Market Cap

12.80B

Enterprise Value

13.85B

Revenue

301.53M

Ranking

n/a

PE Ratio

n/a

Stock Price

€62.18

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.80B, an increase of 338.18%. That is a compound annual growth rate of 25.34%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	12.80B	1.94%
Dec 31, 2025	12.55B	150.63%
Dec 31, 2024	5.01B	-21.16%
Dec 29, 2023	6.35B	496.14%
Dec 30, 2022	1.07B	-50.63%
Dec 31, 2021	2.16B	-69.70%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Jun 27, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	247.30B
Siemens Aktiengesellschaft	197.59B
Allianz SE	145.37B
Deutsche Telekom AG	134.99B
Siemens Energy AG	107.65B
Rheinmetall AG	87.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	67.47B
Deutsche Bank Aktiengesellschaft	63.02B

Market Cap Rankings